Effects of coenzyme Q10 supplementation on the serum levels of amylase, adenosine deaminase, catalase, and total antioxidant capacity in women with type 2 diabetes mellitus: A randomized, double-blind placebo-controlled trial
Open Access
- 1 January 2018
- journal article
- research article
- Published by Medknow in Journal of Research in Medical Sciences
- Vol. 23 (1) , 91
Abstract
Background: Increased levels of reactive oxygen species is a key factor involved in the pathogenesis of type 2 diabetes mellitus (T2DM). Coenzyme Q10(CoQ10) is a nonenzymatic antioxidant that restores other antioxidants. Materials and Methods: This randomized, double-blind placebo-controlled trial study has been designed to evaluate the effects of CoQ10supplementation on serum values of amylase, adenosine deaminase, catalase (CAT), total antioxidant capacity (TAC) and the quantitative insulin sensitivity check index (QUICKI) in women with T2DM. Serum levels of CoQ10were measured too. Sixty-eight women with T2DM were enrolled in this study and randomly divided into two groups. One group received 100 mg/day of CoQ10supplement for 12 weeks (n = 34), and the other group was given placebo for the same time duration and dosage (n = 34). Results: After the intervention, serum CAT activity (P < 0.001), TAC (P = 0.006), CoQ10(P = 0.001), and QUICKI (P = 0.005) increased and fasting blood sugar (FBS) (P = 0.05) decreased significantly in CoQ10group. Conclusion: This study showed that daily supplementation with 100 mg of CoQ10could increase TAC and CAT activity as, CoQ10and QUICKI and could reduce oxidative stress and FBS in women with T2DM.Keywords
This publication has 20 references indexed in Scilit:
- Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndromeJournal of Diabetes & Metabolic Disorders, 2014
- Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic RatsPLOS ONE, 2014
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2013
- Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trialNutrition Journal, 2013
- Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exerciseEuropean Journal of Nutrition, 2011
- Low catalase activity in blood is associated with the diabetes caused by alloxanClinica Chimica Acta, 2009
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usageAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- HPLC method for simultaneous determination of retinol, α-tocopherol and coenzyme Q10 in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP AssayAnalytical Biochemistry, 1996
- [13] Catalase in vitro1984